Trial Outcomes & Findings for Effectiveness of Supplementary Feeding During Infection Among Moderately Malnourished Children (NCT NCT00890695)
NCT ID: NCT00890695
Last Updated: 2017-08-14
Results Overview
The primary endpoint is weight for height z scores (WHZ), calculated from weight and height measures with reference to the WHO growth standards 2006. WHZ is a measure of wasting and acute malnutrition. A WHZ of zero is the median value of the reference population. Negative scores indicate undernutrition. Moderate and severe acute malnutrition are defined as WHZ\<-2 and \<-3 respectively. These correspond to 2 and 3 standard deviations below the reference median. Of all the anthropometric measures in regular use, WHZ and mid upper arm circumference (MUAC) have the strongest associations with infectious disease incidence and risk of death. WHZ is more appropriate than Weight for Age (WAZ), which is normally used in growth monitoring, because WAZ measures a combination of wasting and stunting (chronic malnutrition). Stunting is unlikely to be affected by short term intervention. WHZ is assessed by anthropometry, following WHO guidelines.
TERMINATED
NA
64 participants
between enrolment and 4 weeks
2017-08-14
Participant Flow
Recruitment was started on June 5 2009 and finished on October 8 2009. The study was terminated early because of an inadequate recruitment rate and because a donor-funded supplementary feeding programme targeting moderately malnourished children was started in September 2009.
Of the 7,132 sick children aged 6 months to 5 years seen in outpatients during the study period, 190 with a mid upper arm circumference (MUAC) \<12.5cm were assessed for eligibility. Randomization was carried out on 65 children who were eligible and whose carers consented. 1 was withdrawn: weight for height Z score (WHZ) was found to be \<-3.
Participant milestones
| Measure |
1 Ready to Use Supplementary Food (RUSF)
Products, Kenya. The RUSF composition is in accordance with recommended supplementary feed composition specified by the latest WHO expert consultation in 2008 reported by Golden et al. It is formulated to provide 507 kcal per 100g, 6% protein/energy ratio and 55% fat/energy ratio. Essential fatty acids contained are N-6 (linoleic acid) 6 kcal % and N-3 (o-linoleic) 0.3 kcal %. Vitamin and mineral premix (3%) will provide the currently recommended nutrient intake for moderately malnourished children of minerals (K, Na, Ca, P, Mg, Fe, Zn, Cu, Se, I, Mn, Cr, Mo, F), Vitamins (thiamine, riboflavin, pyridoxine, niacin, Vit B12, folic acid, Vit C, Biotin, Pantothenic acid, Vit A, Vit D,Vit E and Vit K).
initial visit. The amount supplied is based on the child's weight; the recommended energy supplement being 100kcal per kg per day which is equivalent to 25g RUSF per kg per day.
|
2 Normal Diet
For equity, parents or guardians of children in the usual diet arm are given 2 bags of maize meal (4Kg) for family consumption instead of RUSF. All parents and carers in both arms will also receive standard nutritional advice as specified in the current WHO IMCI handbook.
|
|---|---|---|
|
Overall Study
STARTED
|
32
|
33
|
|
Overall Study
COMPLETED
|
31
|
33
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
| Measure |
1 Ready to Use Supplementary Food (RUSF)
Products, Kenya. The RUSF composition is in accordance with recommended supplementary feed composition specified by the latest WHO expert consultation in 2008 reported by Golden et al. It is formulated to provide 507 kcal per 100g, 6% protein/energy ratio and 55% fat/energy ratio. Essential fatty acids contained are N-6 (linoleic acid) 6 kcal % and N-3 (o-linoleic) 0.3 kcal %. Vitamin and mineral premix (3%) will provide the currently recommended nutrient intake for moderately malnourished children of minerals (K, Na, Ca, P, Mg, Fe, Zn, Cu, Se, I, Mn, Cr, Mo, F), Vitamins (thiamine, riboflavin, pyridoxine, niacin, Vit B12, folic acid, Vit C, Biotin, Pantothenic acid, Vit A, Vit D,Vit E and Vit K).
initial visit. The amount supplied is based on the child's weight; the recommended energy supplement being 100kcal per kg per day which is equivalent to 25g RUSF per kg per day.
|
2 Normal Diet
For equity, parents or guardians of children in the usual diet arm are given 2 bags of maize meal (4Kg) for family consumption instead of RUSF. All parents and carers in both arms will also receive standard nutritional advice as specified in the current WHO IMCI handbook.
|
|---|---|---|
|
Overall Study
Protocol Violation
|
1
|
0
|
Baseline Characteristics
Effectiveness of Supplementary Feeding During Infection Among Moderately Malnourished Children
Baseline characteristics by cohort
| Measure |
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=33 Participants
normal diet arm
|
Total
n=64 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
31 Participants
n=5 Participants
|
33 Participants
n=7 Participants
|
64 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
1.21 years
STANDARD_DEVIATION 0.55 • n=5 Participants
|
1.15 years
STANDARD_DEVIATION 0.46 • n=7 Participants
|
1.18 years
STANDARD_DEVIATION 0.50 • n=5 Participants
|
|
Sex: Female, Male
Female
|
26 Participants
n=5 Participants
|
23 Participants
n=7 Participants
|
49 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Region of Enrollment
Kenya
|
31 participants
n=5 Participants
|
33 participants
n=7 Participants
|
64 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: between enrolment and 4 weeksPopulation: All participants recruited until trial was halted
The primary endpoint is weight for height z scores (WHZ), calculated from weight and height measures with reference to the WHO growth standards 2006. WHZ is a measure of wasting and acute malnutrition. A WHZ of zero is the median value of the reference population. Negative scores indicate undernutrition. Moderate and severe acute malnutrition are defined as WHZ\<-2 and \<-3 respectively. These correspond to 2 and 3 standard deviations below the reference median. Of all the anthropometric measures in regular use, WHZ and mid upper arm circumference (MUAC) have the strongest associations with infectious disease incidence and risk of death. WHZ is more appropriate than Weight for Age (WAZ), which is normally used in growth monitoring, because WAZ measures a combination of wasting and stunting (chronic malnutrition). Stunting is unlikely to be affected by short term intervention. WHZ is assessed by anthropometry, following WHO guidelines.
Outcome measures
| Measure |
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=33 Participants
normal diet arm
|
|---|---|---|
|
Weight for Height z Score at 4 Weeks
|
-1.83 units on a scale
Interval -2.15 to -1.51
|
-1.44 units on a scale
Interval -1.65 to -1.22
|
SECONDARY outcome
Timeframe: between enrolment and 3 monthsPopulation: All participants recruited until trial halted
Outcome measures
| Measure |
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=33 Participants
normal diet arm
|
|---|---|---|
|
WHZ Score at 3 Months
|
-1.43 Z scores
Interval -1.68 to -1.18
|
-1.29 Z scores
Interval -1.56 to -1.03
|
SECONDARY outcome
Timeframe: between enrolment and 4 weeks and at 3 monthsPopulation: All participants recruited until trial halted
Outcome measures
| Measure |
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=33 Participants
normal diet arm
|
|---|---|---|
|
MUAC for Age Z Score at 3 Months
|
-1.71 Z score
Interval -1.99 to -1.43
|
-1.62 Z score
Interval -1.95 to -1.28
|
SECONDARY outcome
Timeframe: at 4 weeks and 3 monthsPopulation: All participants recruited until trial halted
Outcome measures
| Measure |
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=33 Participants
normal diet arm
|
|---|---|---|
|
Development of Severe Malnutrition (WHZ Score <-3 and/or Kwashiorkor)
|
4 participants
|
2 participants
|
SECONDARY outcome
Timeframe: at 4 weeksPopulation: All participants recruited until trial halted
Outcome measures
| Measure |
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=33 Participants
normal diet arm
|
|---|---|---|
|
Anemia (Hb <9.3g/dl)
|
16 participants
|
11 participants
|
SECONDARY outcome
Timeframe: from enrolment to 3 monthsPopulation: All participants recruited until trial halted
Outcome measures
| Measure |
1 RUSF
n=31 Participants
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=33 Participants
normal diet arm
|
|---|---|---|
|
Hospital Admission or Death
|
4 participants
|
5 participants
|
Adverse Events
1 RUSF
2 Normal Diet
Serious adverse events
| Measure |
1 RUSF
n=31 participants at risk
RUSF prescribed for the child for 4 weeks
|
2 Normal Diet
n=32 participants at risk
normal diet arm
|
|---|---|---|
|
Gastrointestinal disorders
Gastroenteritis
|
3.2%
1/31 • Number of events 2 • 3 months
|
3.1%
1/32 • Number of events 1 • 3 months
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonia
|
3.2%
1/31 • Number of events 1 • 3 months
|
3.1%
1/32 • Number of events 1 • 3 months
|
|
Metabolism and nutrition disorders
Severe malnutrition
|
6.5%
2/31 • Number of events 3 • 3 months
|
9.4%
3/32 • Number of events 3 • 3 months
|
Other adverse events
Adverse event data not reported
Additional Information
Dr James Berkley
KEMRI/Wellcome Trust Research Programme
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place